AMRX logo

AMRX Amneal Pharmaceuticals, Inc.

NASDAQ Global Select · Drug Manufacturers - Specialty & Generic · Healthcare

$21.12
-0.27 (-1.26%)

Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of therapeutic needs. Its operations are structured into t…

Market Cap: $7.36Bwww.amneal.com

Price

No data yet.

Social Signal Score

56
5d
50
1 mentions
—
30d
57
10 mentions
—
60d
58
12 mentions
—
90d
59
17 mentions
—
news: 12 · rss: 3 · marketaux: 2

Analyst Ratings

18 analysts
Buyconsensus
Strong Buy 0Buy 12Hold 6Sell 0Strong Sell 0
Avg price target$23.43+10.9%
Low $20Median $24High $27
Current Consensus

Revenue

$862.68M+188.93%
$225.68M$438.02M$650.35M$862.68M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$0.80
$0.79–$0.82
4 analysts
FY2026
$1.06+32% YoY
$1.05–$1.08
4 analysts
FY2027
$1.23+16% YoY
$1.15–$1.37
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Chirag K. Patel
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
8,700
Beta
1.21
Country
US
Piotroski score
5 / 9 (Middling)
Altman Z-score
1.96
www.amneal.com